Neonatal screening: from the 'Guthrie age' to the 'genetic age'

Area of Science:

• Medical Genetics
• Public Health
• Biotechnology

Background:

• Newborn screening historically targets severe, frequent, and treatable metabolic or endocrine diseases based on 1960s criteria.
• Recent technological advancements in laboratory testing have expanded the potential scope of newborn screening.

Observation:

• Traditional newborn screening criteria may not encompass all conditions identifiable with new technologies.
• The expansion of screening programs necessitates addressing numerous novel challenges.

Findings:

• Technological progress offers new possibilities for detecting a wider range of conditions in newborns.
• Significant hurdles must be overcome before implementing or broadening newborn screening initiatives.

Implications:

• Future newborn screening programs must adapt to technological capabilities while addressing ethical, logistical, and resource considerations.
• Careful evaluation is required to balance the benefits of expanded screening with potential challenges.